Ascendis Pharma A/S (FRA:A71)
Germany · Delayed Price · Currency is EUR 206.00
+2.00 (0.98%)
Last updated: Apr 17, 2026, 8:00 PM CET
Ascendis Pharma Market Cap
Ascendis Pharma has a market cap or net worth of €12.18 billion as of April 23, 2026.
Market Cap
12.18B
Enterprise Value
12.44B
Revenue
720.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
€206.00
Market Cap Chart
Since April 20, 2026, Ascendis Pharma's market cap has decreased from 12.86B to 12.18B, a decrease of -5.32%. That is a compound annual growth rate of -100.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 12.63B | -1.82% |
| Apr 20, 2026 | 12.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest Aktiengesellschaft | 1.45B |
| Darwin AG | 92.40M |
| 2invest AG | 49.52M |
| Biomark Diagnostics | 35.94M |
| co.don AG | 374.13K |
| bioXXmed AG | 301.77K |
| Paion AG | 271.08K |
| MagForce AG | 122.29K |